Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Endosense (Switzerland), a commercial-stage medical device company focused on catheter ablation for cardiac arrhythmias, closed a $40.3M Series C financing. Participants included NGN Capital, Edmond de Rothschild Investment Partners, NeoMed Management, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

BiO2 Medical (San Antonio, TX) a clinical-stage medical device company focused on catheters for pulmonary embolism in critical care patients, closed a $13.7M Series B financing. Participants include Incyte Capital and Pasadera Capital.

Avinger (Redwood City, CA) a commercial-stage medical device company focused on optical coherence tomography imaging catheters for the treatment of Peripheral Artery Disease, closed a $22.5M Series C financing. Participants were not identified.

Atlanta Catheter Therapies (Chattanooga, TN) a development-stage medical device company focused on catheter technologies for vascular disease, closed a $2.9M Series A financing. Participants were not identified.

Clear Catheter Systems (Bend, OR) a commercial-stage medical device company focused on anti-clogging platforms for surgical drainage in post-surgical recovery, closed a $4.9M Series C financing. Participants include Aphelion Capital, California Technology Ventures and Research Corporation Technologies.

Surefire Medical (Westminster, CO) a development-stage medical device company focused on interventional radiology embolic agent delivery, closed a $6.1M Series A financing. Participants include Partisan Management Group and High Country Venture.

CardioKinetix (Redwood City, CA) a clinical-stage medical device company focused on transcatheter implants for congestive heart failure, closed a $44M Series E financing. Participants include SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners, J.P. Morgan Partners, H&Q Healthcare Investors and H&Q Life Sciences Investors.

Access Scientific (San Diego, CA) a commercial-stage medical device company focused on an over-wire vascular micro-access wand, closed a $10M Series C financing. Participants were not identified. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. Contact […]

Mirador Biomedical (Seattle, WA) a development-stage medical device company focused on single use pressure transducers for use with central venous catheters, closed a $1.5M Series B financing. Participants include WRF Capital and Summit Capital.

Vascular Pathways (Los Altos, CA) a clinical-stage medical device company focused on rapid peripheral intravenous access, closed a $14M Series B financing. Participants include CHL Medical Partners, Ascension Health Ventures, MVM Life Science Partners and Arcus Ventures.

Great Lakes Pharmaceuticals (Cleveland, OH) a clinical-stage drug:device company focused on catheter-related bloodstream infection, closed a $3.1M Series B financing. Participants include Charter Life Sciences, Early Stage Partners, Ohio Tech Angels and North Coast Angel Fund.

Endosense (Switzerland) a commercial-stage medical device company focused on catheter ablation for the treatment of cardiac arrhythmias, closed a $36M Series B financing. Participants include Edmond de Rothschild Investment Partners, Neomed, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital and Initiative Capital Romandie.

Catheter Connections ( Park City, UT) an early-stage focused on accessory products for the prevention of infection in the vascular catheter access device market, closed a $1.3M Series A financing. Participants include vSpring Capital and Kickstart Seed Fund.

« Previous Entries  Next Page »

to top of page...